Jean Pierre Delord

Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma

Fabienne Thomas, Philippe Rochaix, Mélanie White‐Koning et al. · European Journal of Cancer · 2009 · 82 citations

Pharmacy, Oncology, Pharmacokinetics +15

DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death

Benoît Thibault, Ludivine Genre, Augustin Le Naour et al. · Scientific Reports · 2018 · 66 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Abstract LB-122: A phase I dose escalation study of NVP-BGJ398, a selective pan FGFR inhibitor in genetically preselected advanced solid tumors

Jürgen Wolf, Patricia LoRusso, R.D. Camidge et al. · Cancer Research · 2012 · 49 citations

Medicine, Oncology, Pharmacology +15

Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages

Magali Castells, Benoît Thibault, Eliane Mery-Lamarche et al. · Cancer Letters · 2012 · 40 citations

Life Sciences, Cell Biology, Oncology +12

Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series

V. Sibaud, Rachel Niec, Katja Schindler et al. · Breast Cancer Research and Treatment · 2014 · 34 citations

Medicine, Oncology, Pharmacotherapy +16